33
/es/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
2150407
176282
2
Public Timelines
FAQ Obtener premium

23 mayo 2017 año - Pembrolizumab Approved

Descripción:

FDA approved Pembrolizumab for specific tumors which have been identified to have a biomarker referred to as microsatellite instability-high. Meant for those who have undergone other treatments, and with no other alternatives.

Añadido al timeline:

15 nov 2018
0
0
353

fecha:

23 mayo 2017 año
Ahora mismo
~ 8 years and 4 months ago